B2DB — Who said what, where, and when

Activating Anti-tumor Immunity with RNA/DNA Hybrid Agonists of TLR7/8/9

Tides 2027 · 28 April 2027 · 16:45–17:15

Activating Anti-tumor Immunity with RNA/DNA Hybrid Agonists of TLR7/8/9 was a session at Tides 2027 on 28 April 2027 in Boston.